Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00704
|
|||||
| Drug Name |
Cefsulodin
|
|||||
| Synonyms |
(6R,7R)-3-{[4-(aminocarbonyl)pyridinium-1-yl]methyl}-8-oxo-7-{[phenyl(sulfo)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; AC1NR4MP; Cefsulodin free acid (SCE-129), Antibiotic for Culture Media Use Only; DTXSID6022769; SCHEMBL65524
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Pseudomonas infection [ICD11:CA40.05, KB24] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H20N4O8S2
|
|||||
| Canonical SMILES |
C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N
|
|||||
| InChI |
InChI=1S/C22H20N4O8S2/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34)/t15-,17?,21-/m1/s1
|
|||||
| InChIKey |
SYLKGLMBLAAGSC-IKZMBGHXSA-N
|
|||||
| CAS Number |
CAS 52152-93-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 532.6 | Topological Polar Surface Area | 225 | ||
| Heavy Atom Count | 36 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | |||
| XLogP |
0.2
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||||
| 2 | Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999 Jan;16(1):55-61. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.